Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BAYRY

Recent news which mentions BAYRY

< Previous 1 2 3 4 Next >
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Tickers ALT AMGN BAYRY BAYZF
Tags Large Cap Small Cap Biotech
From Benzinga
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
Tickers BAYRY BAYZF NEWS
Tags Market News BAYRY BAYZF
From Benzinga
Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
Tickers BAYRY BAYZF NEWS
Tags Briefs News Biotech
From Benzinga
Top Stocks, Sectors Loved By Congress Members Who Traded In 2023: Apple, NVIDIA, Microsoft, Ford And More Stocks To Watch In 2024
Tickers AAPL ANET BAYRY C
Tags Congress trading UnusualWhales FIS
From Benzinga
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
Tickers BAYRY BAYZF NEWS
Tags Health Care Legal General
From Benzinga
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
Tickers BAYRY BAYZF BLK CTVA
Tags XVV CTVA Olivia Markham
From Benzinga
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
Tickers ABCL BAYRY DNA GOOG
Tags RXRX ABCL INCY
From InvestorPlace
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
Tickers BAYRY BAYZF
Tags Legal General Health Care
From Benzinga
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
Tickers BAYRY BAYZF
Tags Media Market News Benzinga
From Benzinga
PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out
Tickers ARKAY ASGLY BASFY BAYRY
Tags Forever Chemicals Legal DD
From Benzinga
3 Battered Blue-Chip Stocks to Sell in December
Tickers BAYRY BCS SCHW
Tags SCHW Uncategorized BAYRY
From InvestorPlace
German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
Tickers BAYRY BAYZF
Tags Benzinga Market News Media
From Benzinga
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
Tickers BAYRY BAYZF BMY PFE
Tags Reiteration BAYRY Markets
From Benzinga
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
Tickers BAYRY BAYZF BMY PFE
Tags BAYRY BAYZF Markets
From Benzinga
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
Tickers BAYRY BAYZF MRK
Tags Briefs News General
From Benzinga
Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss
Tickers BAYRY BAYZF
Tags Briefs News M&A
From Benzinga
Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss
Tickers BAYRY BAYZF
Tags Briefs News Legal
From Benzinga
Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
Tickers ARKK ARKQ ARKX AVAV
Tags Market News GVDNY RBLX
From InvestorPlace
AI To Revolutionize Clinical Trials And Diagnostics
Tickers AMGN BAYRY MYNZ NVS
Tags AMGN MYNZ artificial intelligence
From Benzinga
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
Tickers AMGN BAYRY BAYZF NVS
Tags NVS Briefs News
From Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Tickers BAYRY CVS GSK HLN
Tags RBGLY KVUE JNJ
From Benzinga
Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories
Tickers AMGN BAYRY BAYZF BV
Tags HZNP SFTBF RNSDF
From Benzinga
German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals
Tickers BAYRY BAYZF BSX
Tags Benzinga BSX BAYRY
From Benzinga
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
Tickers BAYRY BAYZF REGN
Tags BAYRY BAYZF General
From Benzinga
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab?
Tickers BAYRY SNY TLSA
Tags Partner Content SNY Biotech
From Benzinga
Regeneron Pharma Says Fewer Aflibercept Injections Maintains Vision, Anatomic Improvements In Diabetic Macular Edema
Tickers BAYRY REGN
Tags BAYRY Market News Benzinga
From Benzinga
Phase 1 Results Are "Extraordinary," Says Chairman Of Scientific Advisory Board As Biomedical Company Preps Phase 2 Trial For MS Treatment
Tickers BAYRY SNY TSLA
Tags TSLA Partner Content SNY
From Benzinga
AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
Tickers AZN AZNCF BAYRY BAYZF
Tags BAYZF BAYRY General
From Benzinga
Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study
Tickers BAYRY BAYZF
Tags Benzinga BAYZF Market News
From Benzinga
Experimental Stem Cell Therapy For Parkinson's Shows Promise in Phase I Trial: Reuters
Tickers AAPL BAYRY SPOT TSLA
Tags AAPL SPOT Benzinga
From Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.